BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25099617)

  • 1. Calponin-h2: a potential serum marker for the early detection of human breast cancer?
    Debald M; Jin JP; Linke A; Walgenbach KJ; Rauch P; Zellmer A; Fimmers R; Kuhn W; Hartmann G; Walgenbach-Brünagel G
    Tumour Biol; 2014 Nov; 35(11):11121-7. PubMed ID: 25099617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma.
    Alper O; Stetler-Stevenson WG; Harris LN; Leitner WW; Ozdemirli M; Hartmann D; Raffeld M; Abu-Asab M; Byers S; Zhuang Z; Oldfield EH; Tong Y; Bergmann-Leitner E; Criss WE; Nagasaki K; Mok SC; Cramer DW; Karaveli FS; Goldbach-Mansky R; Leo P; Stromberg K; Weil RJ
    Cancer Sci; 2009 Sep; 100(9):1748-56. PubMed ID: 19594548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy.
    Baltzer PA; Dietzel M; Vag T; Burmeister H; Gajda M; Camara O; Pfleiderer SO; Kaiser WA
    Rofo; 2011 May; 183(5):441-7. PubMed ID: 21318935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calponin-h2 is upregulated in the tissues and plasma of patients with breast cancer.
    Ji T; Ma F; Huo L; Guo X; Chen B; Zhou Q
    Mol Med Rep; 2015 Aug; 12(2):2886-92. PubMed ID: 25976781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels and clinical implications of epithelial membrane antigen and cytokeratin-1 in women with breast cancer: can their ratio improve the results?
    Attallah AM; El-Far M; Omran MM; Abdallah SO; El-Desouky MA; El-Dosoky I; Abdelrazek MA; Attallah AA; Elweresh MA; Abdel Hameed GE; Shawki HA; Salama KS; El-Waseef AM
    Tumour Biol; 2014 Nov; 35(11):10737-45. PubMed ID: 25073515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer.
    Kamel AM; Teama S; Fawzy A; El Deftar M
    Tumour Biol; 2016 Jun; 37(6):7565-72. PubMed ID: 26684805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood mammaglobin gene expression for diagnosis and prediction of metastasis in breast cancer patients.
    Radwan WM; Moussa HS; Essa ES; Kandil SH; Kamel AM
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):66-70. PubMed ID: 22897908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Circulating Cell-free Nuclear and Mitochondrial DNA as Potential Biomarkers in the Peripheral Blood of Breast Cancer Patients.
    Mahmoud EH; Fawzy A; Ahmad OK; Ali AM
    Asian Pac J Cancer Prev; 2015; 16(18):8299-305. PubMed ID: 26745076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of G-CSF and IL-7 in Iranian breast cancer patients.
    Bordbar E; Malekzadeh M; Ardekani MT; Doroudchi M; Ghaderi A
    Asian Pac J Cancer Prev; 2012; 13(10):5307-12. PubMed ID: 23244154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midkine in plasma as a novel breast cancer marker.
    Ibusuki M; Fujimori H; Yamamoto Y; Ota K; Ueda M; Shinriki S; Taketomi M; Sakuma S; Shinohara M; Iwase H; Ando Y
    Cancer Sci; 2009 Sep; 100(9):1735-9. PubMed ID: 19538527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.
    Elfagieh M; Abdalla F; Gliwan A; Boder J; Nichols W; Buhmeida A
    Tumour Biol; 2012 Dec; 33(6):2371-7. PubMed ID: 22948780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach.
    Kadowaki M; Sangai T; Nagashima T; Sakakibara M; Yoshitomi H; Takano S; Sogawa K; Umemura H; Fushimi K; Nakatani Y; Nomura F; Miyazaki M
    J Cancer Res Clin Oncol; 2011 Jul; 137(7):1105-15. PubMed ID: 21253761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of endothelin-1 (ET-1) and its precursor (Big ET-1) in breast cancer early diagnosis.
    Kalles V; Zografos GC; Provatopoulou X; Kalogera E; Liakou P; Georgiou G; Sagkriotis A; Nonni A; Gounaris A
    Tumour Biol; 2012 Aug; 33(4):1231-6. PubMed ID: 22415226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs in plasma as early detection markers for breast cancer.
    Cuk K; Zucknick M; Heil J; Madhavan D; Schott S; Turchinovich A; Arlt D; Rath M; Sohn C; Benner A; Junkermann H; Schneeweiss A; Burwinkel B
    Int J Cancer; 2013 Apr; 132(7):1602-12. PubMed ID: 22927033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
    Werling RW; Hwang H; Yaziji H; Gown AM
    Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Second reading of breast imaging at the hospital department of radiology: reasonable or waste of money?].
    Teifke A; Vomweg TW; Hlawatsch A; Nasresfahani A; Kern A; Victor A; Schmidt M; Bittinger F; Düber C
    Rofo; 2006 Mar; 178(3):330-6. PubMed ID: 16508842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
    Cecene G; Ak S; Eskiler GG; Demirdogen E; Erturk E; Gokgoz S; Polatkan V; Egeli U; Tunca B; Tezcan G; Topal U; Tolunay S; Tasdelen I
    Asian Pac J Cancer Prev; 2016; 17(9):4241-4246. PubMed ID: 27797225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall survival and clinicopathological characteristics of patients with breast cancer in relation to the expression pattern of HER-2, IL-6, TNF-α and TGF-β1.
    Tripsianis G; Papadopoulou E; Romanidis K; Katotomichelakis M; Anagnostopoulos K; Kontomanolis E; Botaitis S; Tentes I; Kortsaris A
    Asian Pac J Cancer Prev; 2013; 14(11):6813-20. PubMed ID: 24377611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer.
    Haghbin M; Hashemi Tayer A; Kamravan M; Sotoodeh Jahromi A
    Asian Pac J Cancer Prev; 2021 May; 22(5):1573-1579. PubMed ID: 34048188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.